Pharmacotherapy for erectile dysfunction / 中华男科学杂志
National Journal of Andrology
;
(12): 626-630, 2005.
Artículo
en Chino
| WPRIM
| ID: wpr-339464
ABSTRACT
In the recent few years, especially since the introduction of phosphodiesterase-5 inhibitor, sildenafil, most researchers have focused their researches on biochemistry and physiology of erectile function. New progress has been made made in basic and clinic researches on pharmacotherapy for ED. In this article, the putative molecular or cellular mechanism of actions of the available centrally and peripherally acting drugs are reviewed, providing details about the current and most explosive area of drug research and development in erectile dysfunction.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Farmacología
/
Inhibidores de Fosfodiesterasa
/
Piperazinas
/
Purinas
/
Sulfonas
/
Yohimbina
/
Apomorfina
/
Usos Terapéuticos
/
Quimioterapia
/
Citrato de Sildenafil
Límite:
Animales
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS